Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis.
Devasenapathy N, Chu A, Wong M, Srivastava A, Ceccacci R, Lin C, MacDonald M, Wen A, Steen J, Levine M, Pyne L, Schneider L, Chu DK; AAAAI/ACAAI Joint Task Force on Practice Parameters for Atopic Dermatitis Guideline Development Group. Devasenapathy N, et al. Lancet Child Adolesc Health. 2023 Jan;7(1):13-25. doi: 10.1016/S2352-4642(22)00283-8. Epub 2022 Nov 10. Lancet Child Adolesc Health. 2023. PMID: 36370744
Colchicine to reduce coronavirus disease-19-related inflammation and cardiovascular complications in high-risk patients post-acute infection with SARS-COV-2-a study protocol for a randomized controlled trial.
Thankachen SS, Devasenapathy N, Bassi A, Ghosh A, Arfin S, Gummidi B, Basheer A, Bangi A, Sahu D, Bhalla A, Blesson M, Jain M, Jha V. Thankachen SS, et al. Among authors: devasenapathy n. Trials. 2024 Jun 12;25(1):378. doi: 10.1186/s13063-024-08205-7. Trials. 2024. PMID: 38863076 Free PMC article.
An extension minimal important difference credibility item addressing construct proximity is a reliable alternative to the correlation item.
Wang Y, Devji T, Carrasco-Labra A, Qasim A, Hao Q, Kum E, Devasenapathy N, King MT, Terluin B, Terwee CB, Walsh M, Furukawa TA, Tsujimoto Y, Guyatt GH. Wang Y, et al. Among authors: devasenapathy n. J Clin Epidemiol. 2023 May;157:46-52. doi: 10.1016/j.jclinepi.2023.03.001. Epub 2023 Mar 5. J Clin Epidemiol. 2023. PMID: 36878330
Design and development of a mobile health intervention for rehabilitation support after knee arthroplasty: TeleRehabilitation after knee ArThroplasty (TReAT) project.
Pritwani S, Girotra S, Shrivastava P, Kumar A, Swamy AM, Batra S, Sharma N, John R, Praveen D, Gara S, Malhotra R, Maddison R, Devasenapathy N. Pritwani S, et al. Among authors: devasenapathy n. BMC Musculoskelet Disord. 2024 Nov 7;25(1):890. doi: 10.1186/s12891-024-08003-x. BMC Musculoskelet Disord. 2024. PMID: 39511552 Free PMC article.
Surgery compared to fibrinolytic therapy for symptomatic left-sided prosthetic heart valve thrombosis (SAFE-PVT): Rationale and design of a randomized controlled trial.
Devasenapathy N, Devagourou V, Hote MP, Rajashekar P, Kidambi B, Singal A, Mantoo MR, Soni M, Purohit G, Singh S, Karthikeyan G. Devasenapathy N, et al. Indian Heart J. 2024 May-Jun;76(3):192-196. doi: 10.1016/j.ihj.2024.06.013. Epub 2024 Jun 14. Indian Heart J. 2024. PMID: 38879396 Free PMC article. Clinical Trial.
Correlates of markers of dyssynchrony in patients with STEMI and multivessel disease: an analysis from the IAEA SPECT STEMI trial.
Peix A, Jimenez-Heffernan A, Devasenapathy N, Sobic-Saranovic D, Vitola J, Giubbini R, Rodella C, Haque SU, Alexanderson Rosas E, Ozkan E, Keng YJF, Dondi M, Paez D, Karthikeyan G. Peix A, et al. Among authors: devasenapathy n. Nucl Med Commun. 2024 Aug 1;45(8):666-672. doi: 10.1097/MNM.0000000000001860. Epub 2024 May 15. Nucl Med Commun. 2024. PMID: 38745501 Clinical Trial.
59 results